PXD007538

PXD007538 is an original dataset announced via ProteomeXchange.

Title	Protein data in PHH after VPA-treatment
Description	LC-MS/MS protein data of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout.
HostingRepository	PRIDE
AnnounceDate	2018-02-27
AnnouncementXML	Submission_2018-11-26_02:45:45.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Jarno Wolters
SpeciesList	scientific name: Homo sapiens (Human); NCBI TaxID: 9606;
ModificationList	N-acetylated residue; monohydroxylated residue; iodoacetamide derivatized residue
Instrument	Q Exactive

Revision	Datetime	Status	ChangeLog Entry
0	2017-08-23 06:32:02	ID requested
1	2018-02-27 08:05:38	announced
⏵ 2	2018-11-26 02:45:46	announced	Updated publication reference for PubMed record(s): 29501571.

Wolters JEJ, van Breda SGJ, Grossmann J, Fortes C, Caiment F, Kleinjans JCS, Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett, 289():1-13(2018) [pubmed]

curator keyword: Biological

submitter keyword: Human, Liver

Jarno Wolters
contact affiliation	Department of Toxicogenomics. Maastricht University
contact email	j.wolters@maastrichtuniversity.nl
lab head
Jarno Wolters
contact affiliation	Maastricht University
contact email	j.wolters@maastrichtuniversity.nl
dataset submitter

Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007538

PRIDE project URI

• PRIDE
  1. PXD007538
     1. Label: PRIDE project
     2. Name: Protein data in PHH after VPA-treatment